Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft‐versus‐host disease by inhibiting T‐cell migration to the gastrointestinal tract

INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (aHSCT) is a curative treatment for hematopoietic malignancies. Graft‐versus‐host disease (GVHD) is a major complication of aHSCT. After transplantation, the balance of immune conditions, such as proinflammatory cytokine level and T‐ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubokura, Yukie, Yoshimura, Hideaki, Satake, Atsushi, Nasa, Yutaro, Tsuji, Ryohei, Ito, Tomoki, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425011/
https://www.ncbi.nlm.nih.gov/pubmed/36039651
http://dx.doi.org/10.1002/iid3.688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425011/
https://www.ncbi.nlm.nih.gov/pubmed/36039651
http://dx.doi.org/10.1002/iid3.688

Ejemplares similares